4//SEC Filing
Albanna Amro A. 4
Accession 0001213900-20-019656
CIK 0001726711other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:35 PM ET
Size
10.7 KB
Accession
0001213900-20-019656
Insider Transaction Report
Form 4
Albanna Amro A.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise of In-Money
Series B Warrant
2020-07-24$11.25/sh−35,555$399,994→ 0 total(indirect: See Footnote)Exercise: $0.00From: 2020-07-02Exp: 2025-06-29→ Common Stock (35,555 underlying) - Exercise of In-Money
Series B Warrant
2020-07-24$11.25/sh−38,055$428,119→ 0 totalExercise: $0.00From: 2020-07-02Exp: 2025-06-29→ Common Stock (38,055 underlying) - Exercise of In-Money
Common Stock
2020-07-24$11.25/sh+38,055$428,119→ 476,110 total - Exercise of In-Money
Common Stock
2020-07-24$11.25/sh+35,555$399,994→ 71,110 total(indirect: See Footnote)
Footnotes (1)
- [F1]Held beneficially by the wife of the Reporting Person.
Documents
Issuer
ADiTx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001424733
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:35 PM ET
- Size
- 10.7 KB